Skip to main content

Table 1 Treatment groups

From: Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial

Groups Number of cats s.c. dosage (mean ± SD) in mg/kg Daily oral dosage (mean ± SD) in mg/kg*
Target Actual Target Actual
Robenacoxib (s.c. + oral) 101 2.0 2.0 ± 0.09 1.0 – 2.4 1.58 ± 0.41
Meloxicam (s.c. + placebo oral) 46 0.3 0.3 ± 0.005 - -
  1. s.c.: subcutaneous.
  2. *Robenacoxib and placebo tablets were administered once daily for 9 (range, 7–11) days.